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j.jtcvs.2012.08.017Reply to the Editor:
We thank Drs Ribeiro Neto, Culver,
and Mehta for their comments regard-
ing our study comparing the diagnostic
yield of endobronchial ultrasound-
guided transbronchial needle aspira-
tion (EBUS-TBNA)and transbronchial
lung biopsy (TBLB) by showing non-
caseating granulomas for stage I and
II sarcoidosis.1 We would like to ad-
dress the issues raised by Dr Ribeiro
Neto and colleagues.
The first issue raised concerned pa-
tient selection. Our study included
consecutive patients with suspected
stage I or II sarcoidosis, regardless of
symptoms. We agree that observation
without biopsy for definitive diagnosis
in patients with suspected typical
asymptomatic stage I sarcoidosis is
reasonable; however, we think patho-
logic confirmation of a definitive or
differential diagnosis using a mini-
mally invasive and highly accurate
procedure is another valid choice. In
fact, 33 of the 62 patients enrolled in
our study were referred to our institu-
tion for EBUS-TBNA from physi-
cians at 21 hospitals at which TBLB
was available but not EBUS-TBNA.
We assume this means that many phy-
sicians empirically know the diagnos-
tic yield of TBLB is not sufficient,
especially for stage I sarcoidosis.
Moreover, many of them prefer to
have a pathologic diagnosis for the
treatment of patients with sarcoidosis,
even with asymptomatic stage IThe Journalsarcoidosis, if a highly accurate and
minimally invasive procedure is
available.
The second issue raised regarded
the method of obtaining a final diag-
nosis of sarcoidosis. As we men-
tioned, many patients enrolled in our
study were referred for diagnosis and
returned to be followed up by the re-
ferring physicians. We conducted
a follow-up survey of the patients ask-
ing the physicians regarding the clini-
coradiologic compatibility for having
sarcoidosis. For patients who were
followed up at our institution, we
carefully reviewed the medical re-
cords and radiographs. Finally, the di-
agnosis of sarcoidosis was made by
pulmonologists (M.O., H.S.). In Ja-
pan, the frequency of diseases
(eg, histoplasmosis) other than sar-
coidosis in patients with multiple
hilar-mediastinal lymphadenopathy
presenting with noncaseating epitheli-
oid cell granulomas is quite low, and
a similar result was also reported by
another Japanese group.2
The third issue raised was the limi-
tation of the nonrandomized design.
As we reported in the ‘‘Discussion’’
section, the order of these procedures
could affect the results. A large inter-
national multicenter comparative
study would elucidate more detail on
ultrasound-guided needle aspiration
procedures versus conventional
bronchoscopy.3
At a time when only conventional
procedures (eg, TBLB or mediastino-
scopy) were available for the patho-
logic diagnosis of stage I sarcoidosis,
simple observation without confirma-
tory biopsywas recommended because
of risk/benefit and cost/benefit consid-
erations.4 However, a new approach,
EBUS-TBNA, is a much less-invasive
and more accurate procedure than
these conventional procedures. We in-
vestigators must clarify the role of
this new procedure, even for asymp-
tomatic patients with stage I sarcoido-
sis, in a prospective trial approved
by an institutional review board.of Thoracic and Cardiovascular SurgerArguments advocating for confirma-
tory biopsy for asymptomatic stage I
sarcoidosis were not the aim of our
study; however, the indications should
be debated whenever a promising pro-
cedure is developed.
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j.jtcvs.2012.08.016REGARDING ‘‘VANCOUVER
SIMPLIFIED GRADING
SYSTEM WITH COMPUTED
TOMOGRAPHIC
ANGIOGRAPHY FOR BLUNT
AORTIC INJURY’’
To the Editor:
We read with interest the study on
blunt aortic injury by Lamarche and
colleagues1 and found that the classi-
fication of traumatic aortic injuries
reported in their study was very sim-
ilar to the one we published in 2009.2
Since then, our report has been cited
22 times.3 Among the studies citing
our classification system was the
2011 Clinical Practice Guidelines of
the Society for Vascular Surgery.4
We would like the authors to com-
ment on the differences betweeny c Volume 144, Number 5 1277
